Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 7:50 pm Sale |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Point72 Asset Management, L.P. | 247,055 0.200% |
-4,620,651![]() (-94.92%) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Rubric Capital Management LP | 10,966,672 9.380% |
4,322,142![]() (+65.05%) |
Filing History |
2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
BLACKROCK INC BLK |
9,029,624 7.700% |
0 (Unchanged) |
Filing History |
2024-11-06 4:00 pm Sale |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
MORGAN STANLEY MS |
3,993,787 3.400% |
-2,099,710![]() (-34.46%) |
Filing History |
2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
BLACKROCK INC BLK |
9,029,624 7.700% |
3,113,078![]() (+52.62%) |
Filing History |
2024-03-06 12:40 pm Purchase |
2024-03-04 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,862,478 7.800% |
21,052![]() (+0.24%) |
Filing History |
2024-03-06 10:31 am Purchase |
2024-03-06 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
JENNISON ASSOCIATES LLC | 12,128,533 10.800% |
3,062,451![]() (+33.78%) |
Filing History |
2024-02-14 3:58 pm Purchase |
2024-02-14 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
PRUDENTIAL FINANCIAL INC PRU |
9,884,137 10.470% |
233,326![]() (+2.42%) |
Filing History |
2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
The Vanguard Group | 4,896,513 5.190% |
4,896,513![]() (New Position) |
Filing History |
2024-02-13 12:29 pm Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 9,534,837 9.990% |
-57,375![]() (-0.60%) |
Filing History |
2024-02-13 09:26 am Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Polar Capital Holdings Plc | 6,297,688 6.670% |
-820,256![]() (-11.52%) |
Filing History |
2024-02-12 09:52 am Purchase |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
MORGAN STANLEY MS |
6,093,497 6.500% |
6,093,497![]() (New Position) |
Filing History |
2024-02-12 06:06 am Purchase |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Rubric Capital Management LP | 6,644,530 7.040% |
6,644,530![]() (New Position) |
Filing History |
2024-02-08 12:52 pm Purchase |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
JENNISON ASSOCIATES LLC | 9,066,082 9.600% |
9,066,082![]() (New Position) |
Filing History |
2024-01-31 4:54 pm Purchase |
2024-01-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Point72 Asset Management, L.P. | 4,867,706 5.200% |
3,680,108![]() (+309.88%) |
Filing History |
2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
BLACKROCK INC BLK |
5,916,546 6.300% |
2,036,144![]() (+52.47%) |
Filing History |
2024-01-23 10:26 am Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
STATE STREET CORP STT |
1,525,045 1.620% |
-2,154,340![]() (-58.55%) |
Filing History |
2023-11-16 1:13 pm Purchase |
2023-10-20 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Polar Capital Holdings Plc | 7,117,944 7.560% |
7,117,944![]() (New Position) |
Filing History |
2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
FMR CORP | 3,551,261 3.771% |
-5,587,912![]() (-61.14%) |
Filing History |
2023-11-09 2:54 pm Purchase |
2023-11-09 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
PRUDENTIAL FINANCIAL INC PRU |
9,650,811 10.250% |
9,650,811![]() (New Position) |
Filing History |